Conversely, high levels of cell surface ligand associated with poor prognosis in breast cancer (53), lung (54), and ovarian cancers (43, 55) suggest a failure in NKG2D-mediated tumor surveillance and/or that high levels of surface ligand drives disease progression. This evidence concerns the gene KLRK1 and ovarian cancer.